Economic costs of measles outbreak in the Netherlands, 2013-2014

Post navigation

← Poverty reduction and equity benefits of introducing or scaling up measles, rotavirus, and pneumococcal vaccines in low-income and middle-income countries: a modeling study

Role of healthcare workers in early epidemic spread of Ebola: policy implications of prophylactic compared to reactive vaccination policy in outbreak prevention and control →

VoICE is a project of the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public Health, and is made possible with support from the Bill & Melinda Gates Foundation. We thank the many partners who have contributed their time, energy and expertise to VoICE.

Learn More About IVAC
Contact Us

Translation Disclaimer